Switch theme
Sign up to access all valuation multiples
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 900 laboratories in 61 countries. Its revenue from Europe, North America, and the Rest of the World contribute approximately 50%, 40%, and 10% of total revenue respectively. Its areas of business activity are food, feed, and environmental testing ("Life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
1987
62.7K+
LTM Revenue $8.0B
LTM EBITDA $1.8B
$14.8B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Eurofins Scientific has a last 12-month revenue (LTM) of $8.0B and a last 12-month EBITDA of $1.8B.
In the most recent fiscal year, Eurofins Scientific achieved revenue of $7.8B and an EBITDA of $1.6B.
Eurofins Scientific expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Eurofins Scientific valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $8.0B | XXX | $7.8B | XXX | XXX | XXX |
| Gross Profit | $8.0B | XXX | $5.3B | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 68% | XXX | XXX | XXX |
| EBITDA | $1.8B | XXX | $1.6B | XXX | XXX | XXX |
| EBITDA Margin | 22% | XXX | 20% | XXX | XXX | XXX |
| EBIT | $1.1B | XXX | $816M | XXX | XXX | XXX |
| EBIT Margin | 14% | XXX | 10% | XXX | XXX | XXX |
| Net Profit | $534M | XXX | $456M | XXX | XXX | XXX |
| Net Margin | 7% | XXX | 6% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $2.7B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Eurofins Scientific's stock price is EUR 57 (or $64).
Eurofins Scientific has current market cap of EUR 10.2B (or $11.4B), and EV of EUR 13.2B (or $14.8B).
See Eurofins Scientific trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $14.8B | $11.4B | XXX | XXX | XXX | XXX | $3.83 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Eurofins Scientific has market cap of $11.4B and EV of $14.8B.
Eurofins Scientific's trades at 1.9x EV/Revenue multiple, and 9.4x EV/EBITDA.
Equity research analysts estimate Eurofins Scientific's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Eurofins Scientific has a P/E ratio of 21.4x.
See valuation multiples for Eurofins Scientific and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $11.4B | XXX | $11.4B | XXX | XXX | XXX |
| EV (current) | $14.8B | XXX | $14.8B | XXX | XXX | XXX |
| EV/Revenue | 1.8x | XXX | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | 8.3x | XXX | 9.4x | XXX | XXX | XXX |
| EV/EBIT | 13.6x | XXX | 18.1x | XXX | XXX | XXX |
| EV/Gross Profit | 1.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | 21.4x | XXX | 25.0x | XXX | XXX | XXX |
| EV/FCF | 19.9x | XXX | 16.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialEurofins Scientific's last 12 month revenue growth is 7%
Eurofins Scientific's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Eurofins Scientific's rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Eurofins Scientific's rule of X is 39% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Eurofins Scientific and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 22% | XXX | 20% | XXX | XXX | XXX |
| EBITDA Growth | 7% | XXX | 15% | XXX | XXX | XXX |
| Rule of 40 | 25% | XXX | 27% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 39% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 57% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Sonic Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Bangkok Dusit Medical Services | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Eurofins Scientific acquired XXX companies to date.
Last acquisition by Eurofins Scientific was XXXXXXXX, XXXXX XXXXX XXXXXX . Eurofins Scientific acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Eurofins Scientific founded? | Eurofins Scientific was founded in 1987. |
| Where is Eurofins Scientific headquartered? | Eurofins Scientific is headquartered in France. |
| How many employees does Eurofins Scientific have? | As of today, Eurofins Scientific has 62.7K+ employees. |
| Who is the CEO of Eurofins Scientific? | Eurofins Scientific's CEO is Dr. Gilles G. Martin, PhD. |
| Is Eurofins Scientific publicy listed? | Yes, Eurofins Scientific is a public company listed on PAR. |
| What is the stock symbol of Eurofins Scientific? | Eurofins Scientific trades under ERF ticker. |
| When did Eurofins Scientific go public? | Eurofins Scientific went public in 1997. |
| Who are competitors of Eurofins Scientific? | Similar companies to Eurofins Scientific include e.g. Australian Clinical Labs, Healius, Integral Diagnostics, Sonic Healthcare. |
| What is the current market cap of Eurofins Scientific? | Eurofins Scientific's current market cap is $11.4B |
| What is the current revenue of Eurofins Scientific? | Eurofins Scientific's last 12 months revenue is $8.0B. |
| What is the current revenue growth of Eurofins Scientific? | Eurofins Scientific revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Eurofins Scientific? | Current revenue multiple of Eurofins Scientific is 1.8x. |
| Is Eurofins Scientific profitable? | Yes, Eurofins Scientific is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Eurofins Scientific? | Eurofins Scientific's last 12 months EBITDA is $1.8B. |
| What is Eurofins Scientific's EBITDA margin? | Eurofins Scientific's last 12 months EBITDA margin is 22%. |
| What is the current EV/EBITDA multiple of Eurofins Scientific? | Current EBITDA multiple of Eurofins Scientific is 8.3x. |
| What is the current FCF of Eurofins Scientific? | Eurofins Scientific's last 12 months FCF is $742M. |
| What is Eurofins Scientific's FCF margin? | Eurofins Scientific's last 12 months FCF margin is 9%. |
| What is the current EV/FCF multiple of Eurofins Scientific? | Current FCF multiple of Eurofins Scientific is 19.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
